Premium Content:

Development of injectable HIV treatment progresses

A monthly injection of HIV medication could be as effective as a daily pill regime in treating HIV according to two recent studies.

- Advertisement -

The results of two trials were presented at a health conference in Seattle last week, their findings showing the a monthly injection was as effective as a daily oral three drug regimen.

Research has shown that most people being treated for HIV would opt for a once a month injection over the daily pill taking practice.

The study found that nearly all participants who switched to the long-acting injectable regimen preferred it over their previous treatments.

The research was undertaken by ViiV Healthcare, the data was presented at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, Washington. The two trails are known as Flair and Atlas, and this is third phase of their testing process.

ViiV’s two-drug combo is a combination of its cabotegravir and Janssen, a Johnson & Johnson company’s, Edurant (rilpivirine). The combo is injected every four weeks.

“With FLAIR and ATLAS, we now have positive results from two pivotal Phase III studies demonstrating that this long-acting, once-monthly injectable regimen has similar efficacy, safety and tolerability to a daily, oral three-drug regimen for the treatment of HIV,” said John C. Pottage, Jr., ViiV’s chief scientific and medical officer.

“We are also encouraged by patient preference data showing that nearly all participants who switched to the long-acting injectable regimen preferred it over their prior oral therapy.”

The trials were conducted over 48 weeks and in both trials around 1% of the participants experiences a resistance to the medication.  The company is also investigating if it’s possible to administer the medication in a bi-monthly regime.

The results from the studies will be used to make applications to regulatory bodies in the hope of making the treatment more widely available. For people living with HIV the development means treatment for the virus would change from taking medication 365 days a year, to just 12 clinic appointments.

OIP Staff


Latest

On This Gay Day | The film ‘The Birdcage’ was released

The film was praised for its avoidance of gay stereotypes, and it was a box office smash.

Mardi Gras Film Festival comes to a close an announces award winners

The awards highlight some of the best short films being made in Australia with LGBTIQA+ themes.

Porn sites begin blocking Australian users as new laws come into effect

From Monday watching pornography in Australia will require age verification.

Cory Bernardi says he stands by his comments about gay marriage and bestiality

The former Liberal and Australian Conservatives politician is now with One Nation.

Newsletter

Don't miss

On This Gay Day | The film ‘The Birdcage’ was released

The film was praised for its avoidance of gay stereotypes, and it was a box office smash.

Mardi Gras Film Festival comes to a close an announces award winners

The awards highlight some of the best short films being made in Australia with LGBTIQA+ themes.

Porn sites begin blocking Australian users as new laws come into effect

From Monday watching pornography in Australia will require age verification.

Cory Bernardi says he stands by his comments about gay marriage and bestiality

The former Liberal and Australian Conservatives politician is now with One Nation.

Drag performers have legal win in long running case against Lyle Shelton

There has been a new development in the long...

On This Gay Day | The film ‘The Birdcage’ was released

The film was praised for its avoidance of gay stereotypes, and it was a box office smash.

Mardi Gras Film Festival comes to a close an announces award winners

The awards highlight some of the best short films being made in Australia with LGBTIQA+ themes.

Porn sites begin blocking Australian users as new laws come into effect

From Monday watching pornography in Australia will require age verification.